GHW International announced that it is establishing a new production plant in the western region from existing Tai'an production plant at the Tai'an Daiyue Chemical Industrial Park as part of expansion plan. The new production plant is expected to consist of certain production facilities for (i) the production of trimethylamine, which is the key raw material for the production of choline chloride and betaine, and (ii) the construction of a pilot plant for manufacturing various pharmaceutical intermediates, including methyl iodide, iodopropynyl butyl carbamate ("IPBC") and moxifloxacin side chain. The company believe that expansion to produce trimethylamine at the new production plant will enable to capitalise on the market consolidation opportunities brought about by the challenging market conditions and absorbing the market share from other competitors.

The establishment of pilot plant for manufacturing various pharmaceutical intermediates enables the Group to utilise a small-scale production system to practically test and validate the production technologies of new pharmaceutical intermediate products which were developed by research and development team, before scaling up to a full-scale production.